Temat: "Prednisone" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study.
Autorzy:: Su J; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Xu M; Department of Physical Examination, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Dong Z; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Wang Q; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Ma L; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Xiao P; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Chen X; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2196864.
Typ publikacji:: Journal Article
MeSH Terms:: Azathioprine*/adverse effects
Prednisone*/adverse effects
Purpura, Thrombocytopenic, Idiopathic*/drug therapy
Humans ; Antibodies, Antinuclear ; Immunosuppressive Agents ; Retrospective Studies ; Thrombocytopenia/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Uveal effusion syndrome: a case report.
Autorzy:: Hodges B; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Omoruyi F; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Allison K; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. Karen_.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2024 Mar 21; Vol. 18 (1), pp. 169. Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Glaucoma, Angle-Closure*/therapy
Glaucoma, Angle-Closure*/drug therapy
Uveal Effusion Syndrome*/complications
Humans ; Male ; Aged ; Prednisone/therapeutic use ; Intraocular Pressure ; Eye ; Brimonidine Tartrate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Ensemble effort estimation with metaheuristic hyperparameters and weight optimization for achieving accuracy.
Autorzy:: Yasmin A; Department of Computer and Software Engineering, College of Electrical and Mechanical Engineering, National University of Sciences and Technology (NUST), Islamabad, Pakistan.
Haider Butt W; Department of Computer and Software Engineering, College of Electrical and Mechanical Engineering, National University of Sciences and Technology (NUST), Islamabad, Pakistan.
Daud A; Faculty of Resilience, Rabdan Academy, Abu Dhabi, United Arab Emirates.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 04; Vol. 19 (4), pp. e0300296. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Algorithms*
Exercise*
Machine Learning ; Neural Networks, Computer ; Prednisone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
Autorzy:: Nieto R; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Quintana R; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Zavala-Flores E; Universidad Peruana Cayetano Heredia, Lima, Perú.
Serrano R; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Roberts K; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Catoggio LJ; Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
García MA; Servicio de Reumatología, HIGA San Martin de La Plata, Buenos Aires, Argentina.
Berbotto GA; Servicio de Reumatología, Hospital Escuela 'Eva Perón', Granadero Baigorria, Argentina.
Saurit V; Servicio de Reumatología, Hospital Privado Universitario de Córdoba, Córdoba, Argentina.
Bonfa E; Rheumatology Division, Faculdade de Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Borba EF; Rheumatology Division, Faculdade de Medicina, Hospital das Clinicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Lavras Costallat LT; Universidade Estadual da Campinas, Campinas, Brasil.
Da Silva NA; Servico de Reumatologia, Departamento de Clinica Medica, Faculdade de Medicina, Hospital das Clínicas,Universidade Federal de Goiás, Goiania, Brazil.
Sato EI; Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
Tavares Brenol JC; Rheumatology Division, Department of Internal Medicine, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Massardo L; Centro de Biología Celular y Biomedicina (CEBICEM), Facultad de Medicina y Ciencia, Universidad San Sebastián, Santiago de Chile, Chile.
Neira OJ; Sección de Reumatología, Hospital del Salvador, Universidad de Chile, Unidad de Reumatología, Clínica Alemana de Santiago, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
Vázquez G; Grupo de Inmunología Celular e Inmunogenética, Universidad de Antioquia, Hospital Universitario, Fundación San Vicente, Medellín, Colombia.
Guibert Toledano M; Servicio Nacional de Reumatología, Centro de Investigaciones Médico Quirúrgicas (CIMEQ), La Habana, Cuba.
Pascual-Ramos V; Virginia Pascual-Ramos, Departamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México DF, México.
Sauza Del Pozo MJ; Maria Josefina Sauza del Pozo, Laura E. Aranda Baca, and Adelfia Urenda Quezada, Servicio de Reumatología, Insti- tuto Mexicano de Seguro Social, Hospital de Especialidades No 25, Monterrey, México.
Barile-Fabris LA; Hospital Ángeles del Pedregal, México DF, México.
Amigo MC; Reumatología, Centro Médico ABC, México DF, México.
García De La Torre I; Departamento de Inmunología y Reumatología, Hospital General de Occidente de la S.S. y Universidad de Guadalajara, Zapopan, Jalisco, México.
Acevedo-Vásquez EM; Servicio de Reumatología, Hospital General Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
Segami MI; Servicio de Reumatología, Hospital General Guillermo Almenara Irigoyen, EsSalud, Lima, Peru.
Chacón-Díaz R; Servicio de Reumatología, Policlínica Méndez Gimón, Caracas, Venezuela.
Esteva-Spinetti MH; Servicio de Reumatología, Departamento de Medicina, Hospital Central de San Cristóbal, San Cristóbal, Venezuela.
Alarcón GS; Universidad Peruana Cayetano Heredia, Lima, Perú.; The University of Alabama at Birmingham Marnix E. Heersink School of Medicine, Birmingham, AL, USA.
Pons-Estel BA; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.
Pons-Estel GJ; Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina.; Pokaż więcej
Źródło:: Lupus [Lupus] 2024 Apr; Vol. 33 (4), pp. 340-346. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:: Journal Article
MeSH Terms:: Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/complications
Humans ; Female ; Prednisone/therapeutic use ; Latin America/epidemiology ; Disease Progression ; Hispanic or Latino ; Severity of Illness Index

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: A Rare Case of Donor-Derived Renal Cell Carcinoma in a Kidney Transplant Recipient.
Autorzy:: Sebastian W; West Virginia School of Osteopathic Medicine, Lewisburg, WV, USA.
Omar KO; Department of Pulmonary Critical Care, Charleston Area Medical Center (CAMC), Charleston, WV, USA.
Anees R; Department of Internal Medicine, Charleston Area Medical Center (CAMC), Charleston, WV, USA.
Nagaraju S; Department of Transplant Surgery, Charleston Area Medical Center (CAMC), Charleston, WV, USA.
Chaitanya M; Department of Pulmonary Critical Care, Charleston Area Medical Center (CAMC), Charleston, WV, USA.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2024 Mar 05; Vol. 25, pp. e941214. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Carcinoma, Renal Cell*/surgery
Kidney Neoplasms*/surgery
Kidney Transplantation*
Aged ; Female ; Humans ; Creatinine ; Mycophenolic Acid ; Prednisone

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Development of machine learning-based predictors for early diagnosis of hepatocellular carcinoma.
Autorzy:: Zhang ZM; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Huang Y; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Liu G; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, China.; Fujian Key Laboratory of Medical Bioinformatics, Department of Bioinformatics, School of Medical Technology and Engineering, Fujian Medical University, Fuzhou, 350122, China.
Yu W; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Xie Q; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Chen Z; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Huang G; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Wei J; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Zhang H; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.
Chen D; Fangrui Institute of Innovative Drugs, South China University of Technology, Guangzhou, China.
Du H; School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 04; Vol. 14 (1), pp. 5274. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/diagnosis
Liver Neoplasms*/diagnosis
Humans ; Early Diagnosis ; Liver Cirrhosis ; Machine Learning ; Prednisone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Primary thyroid lymphoma: a case series.
Autorzy:: Sakhri S; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Zemni I; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia. .; LMBA (LR03ES03), Sciences Faculty of Tunis, University Tunis El Manar, Tunis, Tunisia. .
Ayadi MA; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.; LMBA (LR03ES03), Sciences Faculty of Tunis, University Tunis El Manar, Tunis, Tunisia.
Kamoun S; Department of Pathology, Salah Azaïz Institute, Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia.
Chargui R; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Ben Dhiab T; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2024 Feb 24; Vol. 18 (1), pp. 108. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Thyroid Neoplasms*/pathology
Lymphoma, Non-Hodgkin*
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/therapy
Lymphoma, Large B-Cell, Diffuse*/pathology
Male ; Humans ; Female ; Aged ; Rare Diseases ; Doxorubicin/therapeutic use ; Prednisone/therapeutic use ; Vincristine/therapeutic use ; Rituximab ; Cyclophosphamide/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88 diffuse large B-cell lymphoma.
Autorzy:: Deng T; Department of Hematology, Chongqing Fifth People's Hospital, Chongqing, PR China.
Zhang S; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Xiao M; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Gu J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.
Zhou X; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7005.
Typ publikacji:: Journal Article
MeSH Terms:: Myeloid Differentiation Factor 88*/genetics
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Lymphoma, Large B-Cell, Diffuse*/pathology
Piperidines*
Pyridines*
Humans ; Aged ; Rituximab/therapeutic use ; Disease-Free Survival ; Retrospective Studies ; Vincristine/adverse effects ; Cyclophosphamide/adverse effects ; Doxorubicin/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Prednisone/adverse effects ; CD79 Antigens/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Comparison of two corticosteroid regimens on brain volumetrics in patients with Duchenne muscular dystrophy.
Autorzy:: Geuens S; Child Neurology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Van Dessel J; Department of Neurosciences, Center for Developmental Psychiatry, UPC-KU Leuven, Leuven, Belgium.
Govaarts R; C.J. Gorter MRI Center, Radiology, Leiden University Medical Center, Leiden, Netherlands.; Duchenne Center Netherlands, Leiden, Netherlands.
Ikelaar NA; Duchenne Center Netherlands, Leiden, Netherlands.; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.
Meijer OC; Department of Medicine, Leiden University Medical Center, Leiden, Netherlands.
Kan HE; C.J. Gorter MRI Center, Radiology, Leiden University Medical Center, Leiden, Netherlands.; Duchenne Center Netherlands, Leiden, Netherlands.
Niks EH; Duchenne Center Netherlands, Leiden, Netherlands.; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.
Goemans N; Child Neurology, University Hospitals Leuven, Leuven, Belgium.
Lemiere J; Pediatric Hemato-Oncology, University Hospitals Leuven, Leuven, Belgium.; Department Oncology, Pediatric Oncology, KU Leuven, Leuven, Belgium.
Doorenweerd N; C.J. Gorter MRI Center, Radiology, Leiden University Medical Center, Leiden, Netherlands.
De Waele L; Child Neurology, University Hospitals Leuven, Leuven, Belgium.; Department of Development and Regeneration, KU Leuven, Leuven, Belgium.; Pokaż więcej
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Dec; Vol. 10 (12), pp. 2324-2333. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Muscular Dystrophy, Duchenne*/diagnostic imaging
Muscular Dystrophy, Duchenne*/drug therapy
Muscular Dystrophy, Duchenne*/genetics
Humans ; Child ; Adolescent ; Cross-Sectional Studies ; Adrenal Cortex Hormones/pharmacology ; Adrenal Cortex Hormones/therapeutic use ; Brain/diagnostic imaging ; Brain/pathology ; Prednisone/pharmacology ; Prednisone/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Successful Management of Refractory Kimura Disease with CVP Chemotherapy: A Case Report.
Autorzy:: Heo J; Department of Ophthalmology, Pusan National University College of Medicine, Busan, South Korea.
Choi HY; Department of Ophthalmology, Pusan National University College of Medicine, Busan, South Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.
Park J; Department of Ophthalmology, Pusan National University College of Medicine, Busan, South Korea.; Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2024 Jan 29; Vol. 25, pp. e942753. Date of Electronic Publication: 2024 Jan 29.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Kimura Disease*/drug therapy
Angiolymphoid Hyperplasia with Eosinophilia*/diagnosis
Angiolymphoid Hyperplasia with Eosinophilia*/drug therapy
Angiolymphoid Hyperplasia with Eosinophilia*/pathology
Female ; Humans ; Middle Aged ; Prednisone/therapeutic use ; Vincristine/therapeutic use ; Adrenal Cortex Hormones/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: A review of 17 cases of mesenteric panniculitis in Zhengzhou Ninth People's Hospital in China.
Autorzy:: Wang H; Geriatric Center, Zhengzhou Ninth People's Hospital, 25 Sha Kou Road, 450008, Zhengzhou, Henan, China.
Zhao Z; Radiology, Zhengzhou Ninth People's Hospital, 25 Sha Kou Road, 450008, Zhengzhou, Henan, China.
Cao Q; Geriatric Center, Zhengzhou Ninth People's Hospital, 25 Sha Kou Road, 450008, Zhengzhou, Henan, China.
Ning J; Geriatric Center, Zhengzhou Ninth People's Hospital, 25 Sha Kou Road, 450008, Zhengzhou, Henan, China. .; Pokaż więcej
Źródło:: BMC gastroenterology [BMC Gastroenterol] 2024 Jan 24; Vol. 24 (1), pp. 48. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Panniculitis, Peritoneal*/complications
Panniculitis, Peritoneal*/diagnosis
Panniculitis, Peritoneal*/therapy
Humans ; Female ; Male ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Prednisone ; Neoplasm Recurrence, Local ; China ; Abdominal Pain/etiology ; Anti-Bacterial Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Long-term outcomes with HLX01 (HanliKang ), a rituximab biosimilar, in previously untreated patients with diffuse large B-cell lymphoma: 5-year follow-up results of the phase 3 HLX01-NHL03 study.
Autorzy:: Qin Y; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China.
Song Y; Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wang D; Department of Oncology, Army Characteristic Medical Center, Chongqing, China.
Bai O; Department of Hematology, Cancer Center, the First Hospital of Jilin University, Changchun, China.
Feng J; Department of Oncology, Jiangsu Cancer Hospital, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Nanjing, China.
Sun X; Department of Medical Oncology, the Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Qiu L; Department of Lymphoma, Tianjin Medical University Cancer Hospital, Tianjin, China.
Yang J; Department of Hematology, Changhai Hospital, Naval Medical University, Shanghai, China.
Yang Y; Department of Lymphoma & Head and Neck Tumors, Fujian Medical University Cancer Hospital, Fuzhou, China.
Wang Z; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Hu J; Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
Wang H; Department of Medical Oncology, Tianjin Union Medical Centre of Nankai University, Tianin, China.
Su H; Department of Lymphoma, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China.
Jin Z; Department of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China.
Qian W; Department of Hematology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Jin C; Department of Oncology, Guangzhou Medical University, Guangzhou, China.
Zhang M; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yu D; Department of Oncology Medicine, Hubei Cancer Hospital, Wuhan, China.
Liu L; Department of Hematology, the Second Affiliated Hospital of Air Force Medical University (Tangdu Hospital), Xian, China.
Chen G; Department of Hematology, the First Affiliated Hospital of Nanchang University, Nanchang, China.
Li Y; Hematology and Oncology Department, the Second Hospital of Jilin University, Changchun, China.
Sun T; Department of Breast Medicine, Liaoning Cancer Hospital, Shenyang, China.
Jin J; Department of Hematology, the First Affiliated Hospital of Medical College of Zhejiang University, Hangzhou, China.
Bao H; Department of Lymphology and Hematology, Jilin Provincial Cancer Hospital, Changchun, China.
Du X; Department of Hematology, Guangdong Provincial People's Hospital, Guangzhou, China.
Zhou H; Department of Lymphoma & Hematology, Hunan Cancer Hospital, Changsha, China.
Fu G; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Shi Y; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, 100021, Beijing, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 24; Vol. 24 (1), pp. 124. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Biosimilar Pharmaceuticals*/adverse effects
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Humans ; Rituximab/adverse effects ; Follow-Up Studies ; Cyclophosphamide/adverse effects ; Doxorubicin ; Prednisone/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study.
Autorzy:: Zhang KY; Department of Neurology, Xiangya Hospital, Central South University, Xiangya Road, Kaifu District, Changsha, 410008, China.
Duan WW; Department of Neurology, Xiangya Hospital, Central South University, Xiangya Road, Kaifu District, Changsha, 410008, China.
Luo YB; Department of Neurology, Xiangya Hospital, Central South University, Xiangya Road, Kaifu District, Changsha, 410008, China.
Li Y; Department of Neurology, Xiangya Hospital, Central South University, Xiangya Road, Kaifu District, Changsha, 410008, China.
Hu J; Department of Neurology, Changsha Central Hospital, Changsha, China.
Yang H; Department of Neurology, Xiangya Hospital, Central South University, Xiangya Road, Kaifu District, Changsha, 410008, China. .; Pokaż więcej
Źródło:: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Jan 19; Vol. 19 (1), pp. 19. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:: Journal Article
MeSH Terms:: Methylprednisolone*/therapeutic use
Myasthenia Gravis*/drug therapy
Humans ; Prednisone/therapeutic use ; Retrospective Studies ; Tacrolimus/therapeutic use ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Learning from cerebrospinal fluid drug-resistant HIV escape-associated encephalitis: a case report.
Autorzy:: Kang J; National Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Hospital of China Medical University, Shenyang, China.; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, China.
Wang Z; Dongguan Institute for Microscale and Precision Medical Measurement, Dongguan, China.
Zhou Y; Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China.
Wang W; Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China.
Wen Y; Department of Infectious Diseases, The First Affiliated Hospital of China Medical University, No. 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China. .; Pokaż więcej
Źródło:: Virology journal [Virol J] 2023 Dec 10; Vol. 20 (1), pp. 292. Date of Electronic Publication: 2023 Dec 10.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Anti-HIV Agents*/pharmacology
Encephalitis*/complications
Encephalitis*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
Adult ; Humans ; Male ; Cerebrospinal Fluid ; Lamivudine/therapeutic use ; Prednisone/therapeutic use ; RNA ; RNA, Viral/genetics ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
Autorzy:: Wilf-Yarkoni A; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Feldmann K; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Emergency and Acute Medicine, Campus Mitte and Virchow, Charité -Universitätsmedizin Berlin, Berlin, Germany.
Rubarth K; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Charité Universitaetsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Berlin, Germany.
Dorsch EM; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Rust R; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health (BIH), Berlin, Germany.
Urman I; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Hellmann MA; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Friedman Y; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lotan I; Neuroimmunology Unit, Department of Neurology, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Bialer O; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Tel Aviv University, Tel Aviv, Israel.; Neuro-Ophthalmology Unit, Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.
Buenrostro GS; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Zimmermann HG; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Leutloff C; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Schmitz-Hübsch T; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Paul F; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Asseyer S; Experimental and Clinical Research Center, a Cooperation Between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin, Berlin, Germany.; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Experimental and Clinical Research Center, Berlin, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.; Neuroscience Clinical Research Center, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Stiebel-Kalish H; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Felsenstein Medical Research Center, Tel Aviv University, Tel Aviv, Israel.; Neuro-Ophthalmology Unit, Department of Ophthalmology, Rabin Medical Center, Petah Tikva, Israel.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Dec 07; Vol. 18 (12), pp. e0288366. Date of Electronic Publication: 2023 Dec 07 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/diagnosis
Optic Neuritis*/complications
Adult ; Humans ; Male ; Infant ; Female ; Methylprednisolone/therapeutic use ; Prednisone/therapeutic use ; Retrospective Studies ; Prospective Studies ; Tomography, Optical Coherence/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Outcome and patterns of relapse in primary gastric diffuse large B cell lymphoma treated with RCHOP.
Autorzy:: Ma'koseh M; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Farfoura H; Department of Radiology, King Hussein Cancer Center, Amman, Jordan.
Abufara A; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Elmusa R; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Hushki A; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Faqeer N; Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.
Ghatasheh H; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
Shahin O; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Alawabdeh T; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Al-Rwashdeh M; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Halahleh K; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Al-Ibraheem A; Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
Alrabi K; Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2198898.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*
Humans ; Disease-Free Survival ; Prednisone ; Rituximab/therapeutic use ; Cyclophosphamide ; Vincristine ; Doxorubicin ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma.
Autorzy:: Kristjanson M; Department of Family Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.; Urgent Cancer Care, CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.
Lambert P; Paul Albrechtsen Research Institute CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.
Decker KM; Paul Albrechtsen Research Institute CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.; Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, 750 Bannatyne Avenue, Winnipeg, MB R3E 0W2, Canada.
Bruin S; Ongomiizwin Health Services Institute of Indigenous Health and Healing, 745 Bannatyne Avenue, Winnipeg, MB R3E 3N4, Canada.
Tingey E; Max Rady College of Medicine, Rady Faculty of Health Sciences 750 Bannatyne Avenue, Winnipeg, MB R3E 0W2, Canada.
Skrabek P; Department of Medical Oncology & Hematology, CancerCare Manitoba, 675 McDermot Avenue, Winnipeg, MB R3E 0V9, Canada.; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0W2, Canada.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Nov 28; Vol. 30 (12), pp. 10142-10151. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphoma, Large B-Cell, Diffuse*/drug therapy
Hyperglycemia*/chemically induced
Hyperglycemia*/drug therapy
Humans ; Retrospective Studies ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Prednisone/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Diffuse Large B-Cell Lymphoma with Cutaneous Manifestations in a Young Patient Using Clozapine for Schizophrenia: A Case Report.
Autorzy:: Moraes de Brito MC; Department of Internal Medicine, Hospital das Clínicas of Federal University of Pernambuco, Recife, PE, Brazil.; Department of Research, Autoimune Research Institute, Recife, PE, Brazil.
Guedes MMV; Department of Internal Medicine, Hospital das Clínicas of Federal University of Pernambuco, Recife, PE, Brazil.
Nascimento JDS; Department of Hematology, Hospital das Clínicas of Federal University of Pernambuco, Recife, PE, Brazil.
Pimentel Jatobá V; Department of Internal Medicine, Hospital das Clínicas of Federal University of Pernambuco, Recife, PE, Brazil.
Alves Junior MP; Department of Internal Medicine, Hospital das Clínicas of Federal University of Pernambuco, Recife, PE, Brazil.
Lira AC; Department of Psychiatry, Hospital das Clínicas of Federal University of Pernambuco, Recife, PE, Brazil.
Gouveia PADC; Department of Internal Medicine, Hospital das Clínicas of Federal University of Pernambuco, Recife, PE, Brazil.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2023 Nov 21; Vol. 24, pp. e941746. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Clozapine*/adverse effects
Lymphoma, Large B-Cell, Diffuse*/pathology
Schizophrenia*/drug therapy
Skin Diseases*/drug therapy
Adult ; Female ; Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide ; Doxorubicin/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Prednisone/therapeutic use ; Rituximab/therapeutic use ; Vincristine

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Leprosy with type 1 reaction in a patient from Ontario, Canada without recent travel misdiagnosed as vasculitic neuropathy: a case report.
Autorzy:: Driedger M; University of Ottawa, Ottawa, ON, Canada. .
Teo I; University of Ottawa, Ottawa, ON, Canada.; Division of Anatomical Pathology, The Ottawa Hospital, Ottawa, ON, Canada.
Roth V; University of Ottawa, Ottawa, ON, Canada.; The Ottawa Hospital, Ottawa, ON, Canada.; The Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Nov 21; Vol. 23 (1), pp. 815. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Arthritis, Rheumatoid*/drug therapy
Exanthema*/drug therapy
Leprosy*/complications
Leprosy*/diagnosis
Leprosy*/drug therapy
Aged, 80 and over ; Humans ; Male ; Delayed Diagnosis ; Diagnostic Errors ; Mycobacterium leprae ; Ontario ; Paresthesia/drug therapy ; Prednisone

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Tongue and teeth hyperpigmentation in etoposide, prednisolone, vincristine, and cyclophosphamide regimen in the treatment of cutaneous lymphoma.
Autorzy:: Morabad SS; Department of Pharmacy Practice, B. V. V. S. Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote, Karnataka, India.
Khan ZU; Department of Pharmacy Practice, B. V. V. S. Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote, Karnataka, India.
Gad R; Department of Pharmacy Practice, B. V. V. S. Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote, Karnataka, India.
Kallur N; Department of Pharmacy Practice, B. V. V. S. Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote, Karnataka, India.
Madhabhavi IV; Department of Medical and Pediatric Oncology and Hematology, Kerudi Cancer Hospital, Bagalkote, Karnataka, India.
Shalavadi MH; Department of Pharmacy Practice, B. V. V. S. Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote, Karnataka, India.
Mangannavar CV; Department of Pharmacy Practice, B. V. V. S. Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote, Karnataka, India.; Pokaż więcej
Źródło:: Indian journal of pharmacology [Indian J Pharmacol] 2023 Nov-Dec; Vol. 55 (6), pp. 405-407.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Lymphoma, Non-Hodgkin*/drug therapy
Lymphoma, Non-Hodgkin*/pathology
Lymphoma*/drug therapy
Skin Neoplasms*
Hyperpigmentation*/chemically induced
Hyperpigmentation*/drug therapy
Humans ; Vincristine/adverse effects ; Etoposide/adverse effects ; Prednisolone/adverse effects ; Prednisone/therapeutic use ; Doxorubicin/adverse effects ; Cyclophosphamide/adverse effects ; Tongue/pathology ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Prednisone"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji